oseltamivir has been researched along with Chronic Lung Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, Y; Bao, L; Cao, B; Jia, X; Li, F; Li, H; Liu, B; Lv, Q; Wang, C; Zhang, X | 1 |
Engelhard, D; Glikman, D; Hindiyeh, M; Mandelboim, M; Mendelson, E; Ram, D; Zonis, Z | 1 |
2 other study(ies) available for oseltamivir and Chronic Lung Injury
Article | Year |
---|---|
Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Dogs; Drug Therapy, Combination; Epithelial Cells; Female; Inflammasomes; Influenza A Virus, H1N1 Subtype; Interleukin-18; Interleukin-1beta; Lung; Lung Injury; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred BALB C; NLR Family, Pyrin Domain-Containing 3 Protein; Oseltamivir; Reactive Oxygen Species; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2018 |
Community-acquired oseltamivir-resistant pandemic (H1N1) 2009 in child, Israel.
Topics: Accidents, Traffic; Antiviral Agents; Child, Preschool; Community-Acquired Infections; Contusions; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Israel; Lung Injury; Male; Oseltamivir; Respiratory Distress Syndrome; Time Factors | 2010 |